Pembrolizumab Approved to Treat Metastatic Small Cell Lung Cancer - Pulmonology Advisor

Pembrolizumab Approved to Treat Metastatic Small Cell Lung Cancer  Pulmonology Advisor

The Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab; Merck) for the treatment of patients with metastatic small cell lung cancer ...



Comments

Popular posts from this blog

Oncology: The disease, dynamics & challenges of market research

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Lung Cancer Among People Who Never Smoked